Who we are?
We believe genome editing redefine
how we may thrive meeting Sustainable Development Goals.
Founded by Prof Mashimo from the University of Tokyo, we have developed proprietary gene editing techniques such as one using CRISPR/Cas3 that is characterized by its unprecedentedly high target sequence specificity (safety in medical term) and large scale edition (translated to efficient knock-out). We are looking for collaboration partners to co-develop innovative products.
Tech Alliance Tower C
The entrance of Tech Alliance Tower C
Genome editing to disrupt every biotech-related industries